Colorectal Cancer Screening Amid <scp>COVID‐19</scp> in Japan: Analysis From the 2021–2022 <scp>JACSIS</scp> Study
Although CRC screening rates increased from 2021 to 2022, a significant proportion of respondents still reported not undergoing screening, highlighting the importance of assessing the long-term impact of COVID-19 and identifying factors that make screening less accessible.
Authors
- Akihiko Ozaki (ORCID: https://orcid.org/0000-0003-4415-9657)
- Yudai Kaneda (ORCID: https://orcid.org/0000-0001-8302-9439)
- Aminu Kende Abubakar (ORCID: https://orcid.org/0009-0009-8902-081X)
- Takahiro Tabuchi (ORCID: https://orcid.org/0000-0002-1050-3125)
- Michio Murakami (ORCID: https://orcid.org/0000-0002-5557-9801)
- Hiroaki Saito (ORCID: https://orcid.org/0000-0002-0824-454X)
- Daisuke Hori (ORCID: https://orcid.org/0000-0001-5832-9923)
- Masaharu Tsubokura (ORCID: https://orcid.org/0000-0001-8027-202X)
Institutions
- Fukushima Medical University (JP)
- University of Tsukuba (JP)
- Tohoku University (JP)
- Hokkaido University (JP)
- St. Luke's International University (JP)
- Jyoban Hospital of Tokiwa Foundation (JP)
- Soma Central Hospital (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/cam4.70859
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Japan Society for the Promotion of Science